Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M. Netsch
Development of a Pharmacokinetic (PK) Model and Assessment of Patient (Pt) Covariate Effects on Dose-Dependent PK Following Different Dosing Schedules in Two Phase I Trials of AP23573 (AP), a mTOR Inhibitor
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Related publications
First-In-Human Phase I Study of a Dual mTOR Kinase and DNA-PK Inhibitor (CC-115) in Advanced Malignancy
Cancer Management and Research
Oncology
Pharmacokinetic/Pharmacodynamic (PK/PD) Indices of Antibiotics Predicted by a Semimechanistic PKPD Model: A Step Toward Model-Based Dose Optimization
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Pharmacokinetic/Pharmacodynamic (PK/PD) Modeling of Anti-Neoplastic Agents
In House Training Pada Perawat PK I-Pk IV Terhadap Pengetahuan Tentang Manajemen Nyeri
Klabat Journal of Nursing
Population Pharmacokinetic Assessment of Vancomycin Dosing in the Large Pediatric Patient
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
The Pharmacokinetic (PK) Interaction Between Omeprazole and TMC278, an Investigational Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI)
Journal of the International AIDS Society
Environmental
Public Health
Infectious Diseases
Occupational Health
A Phase I Trial and PK Study of Cediranib (AZD2171), an Orally Bioavailable Pan-Vegfr Inhibitor, in Children With Recurrent or Refractory Primary CNS Tumors
Child's Nervous System
Medicine
Child Health
Neurology
Pediatrics
Perinatology
Phase I and Pharmacokinetic Study of YM155, a Small-Molecule Inhibitor of Survivin
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Dalbavancin Alone and in Combination With Ceftaroline Against Four Different Phenotypes of Staphylococcus Aureus in a PK/PD Model
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
